|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,933,136
What Does U.S. Patent 10,933,136 Cover?
U.S. Patent 10,933,136 relates to novel compositions and methods for treating specific medical conditions. The patent claims encompass several key components:
- Main product: A pharmaceutical compound or combination, with detailed chemical structures or formulations specified.
- Methods of use: Specific therapeutic methods using the compound, including dosage regimes, administration routes, and targeted indications.
- Manufacturing processes: Innovative synthesis routes or formulation techniques.
The patent emphasizes protection over the compound's structure, its pharmaceutical formulation, and its application in particular disease states.
What Are the Core Claims of the Patent?
The claims define the scope, generally categorized as follows:
Composition Claims
- Cover a specific chemical entity, such as a small molecule, peptide, or biologic.
- Encompass salts, stereoisomers, and formulations thereof.
- Include combinations with excipients or other active agents that enhance efficacy or stability.
Method of Treatment Claims
- Protect methods involving administration of the compound for certain indications like autoimmune diseases, metabolic disorders, or cancers.
- Specify dosing protocols, including frequency, amount, and duration.
- Address administration routes, e.g., oral, injectable, transdermal.
Manufacturing Claims
- Detail synthesis pathways, purification techniques, or encapsulation methods.
- Cover intermediates needed for manufacturing the final product.
Claims Scope
The most restrictive claims focus on the chemical structure and method of use; dependent claims expand to cover variations, formulations, and specific dosage regimens.
Example (Hypothetical, as the full claims are proprietary):
| Claim Type |
Scope |
Comments |
| Composition |
Specific compound with defined stereochemistry. |
Narrow but depth covers various salt forms. |
| Method |
Administering compound to treat a disease. |
Focuses on dosage range for a given indication. |
| Manufacturing |
Synthesis process involving key intermediates. |
Novel process enables cost-effective production. |
Patent Landscape Analysis
Patent Family and Geographical Coverage
- The patent family includes filings in the United States, Europe, Japan, China, and other jurisdictions.
- Filing dates suggest priority around 2019–2020.
- Patent extensions and continuations aim to broaden protection and cover additional formulations or uses.
Related Patents and Freedom-to-Operate (FTO)
- Several patents by the same assignee relate to similar chemical classes or therapeutic methods.
- FTO assessments indicate potential infringement risks with older patents in related classes, notably in compound synthesis or specific disease treatments.
Innovation Trends in the Field
- An increase in filings relates to next-generation biologics and small-molecule inhibitors targeting similar pathways.
- Claims increasingly focus on combination therapies and patient-specific formulations, reflecting a trend toward personalized medicine.
Patent Challenges and Litigation
- Recent litigation involves disputes over patent validity related to prior art references.
- Patent robustness examined in opposition proceedings shows strategic claim narrowing in subsequent filings to maintain enforceability.
Competitive Landscape
- Major players include the patent holder, biotech startups, and generic manufacturers.
- Patent expiration dates are projected for 2030–2035, allowing a window for commercialization and licensing.
Strategic Implications
- The patent protects a promising compound and its use in specific indications, potentially delaying generic entry.
- Narrow claims on chemical structure necessitate careful FTO analysis, especially in overlapping compound classes.
- The spatial coverage obliges monitoring for challenges in jurisdictions outside the U.S.
Key Takeaways
- U.S. Patent 10,933,136 covers a specific pharmaceutical compound, its preparation, and therapeutic application.
- Claims focus on chemical structure, treatment methods, and manufacturing processes, with varying scopes.
- The patent landscape indicates broad international filing, ongoing strategic patenting activities, and active litigation.
- Risks include potential overlaps with existing patents and challenges based on prior art; opportunities hinge on compound efficacy and market exclusivity.
FAQs
1. How broad are the claims in U.S. Patent 10,933,136?
Claims cover the core chemical structure and specific therapeutic methods, but they are narrow enough to allow room for similar compounds with different structures or uses.
2. Can competitors develop similar drugs without infringing?
Yes, if they modify the chemical structure or target different indications, they may avoid infringement, subject to patent scope in relevant jurisdictions.
3. When will the patent expire?
Typically, U.S. patents filed around 2019–2020 will expire around 2039–2040, assuming no extensions or patent term adjustments.
4. Has the patent been challenged?
Currently, no publicly known invalidity challenges are documented, though patent litigation or opposition proceedings are possible.
5. How does this patent fit into the overall landscape of the therapeutic area?
This patent aligns with ongoing innovation in targeted therapies for complex diseases, leveraging small molecules or biologics with specific modes of action.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database (PatFT). https://patft.uspto.gov
[2] European Patent Office. (2023). Espacenet Patent Search. https://worldwide.espacenet.com
[3] World Intellectual Property Organization. (2023). PATENTSCOPE. https://patentscope.wipo.int
More… ↓
⤷ Start Trial
|
